COVID-19 mutations have already reached the US and could impact existing vaccines and tests during the pandemic, the FDA has said, confirming that new regulations are being worked on that will hopefully streamline variant-focused updates to healthcare. However the Food and Drug Administration says that, for the moment at least, it believes the risk of mutations on existing molecular testing …
Please to comment